Beaumont G
J Int Med Res. 1977;5(1 Suppl):32-6.
Patients treated with four dosage regimes of clomipramine (Anafranil) 10 mg t.d.s., 30 mg o.n., 25 mg t.d.s. and 75 mg o.n. in a clinical trial lasting four weeks were regularly weighed. Due allowance was made for the normality or otherwise of normal weight, appetite and, in women, menstruation. There was no evidence that during the four weeks of this particular study and on these doses of clomipramine patients showed any increase in weight.
在一项为期四周的临床试验中，对接受四种氯米帕明（安拿芬尼）给药方案（每日三次，每次10毫克；每晚30毫克；每日三次，每次25毫克；每晚75毫克）治疗的患者定期称重。充分考虑了体重、食欲的正常与否，以及女性的月经情况。没有证据表明在这项特定研究的四周期间，使用这些剂量的氯米帕明的患者体重有任何增加。
